Natera is an Austin-based diagnostics and genetic testing company that participates as a strategic corporate investor in life sciences financings. Its investment activity includes later-stage venture exposure in the United States, with relevance for Biotechnology, HealthTech, Life Sciences and Oncology companies where genetic testing, molecular diagnostics or genomics alignment matters.